$BCRD
BlueOne Card, Inc. Stock $bcrd

$bcrd Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041252 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$1.000K	$3.000K
YoY Change
Cost Of Revenue	$400.00	$1.200K
YoY Change
Gross Profit	$600.00	$1.800K
YoY Change
Gross Profit Margin	60.0%	60.0%
Selling, General & Admin	$437.6K	$413.5K	$136.4K
YoY Change	238.34%	203.15%	-12.67%
% of Gross Profit	72930.0%	22971.67%
Research & Development	$61.96K	$17.64K
YoY Change
% of Gross Profit	10326.67%	980.0%
Depreciation & Amortization	$32.36K	$28.75K	$8.117K
YoY Change	399.07%	254.21%	-22.84%
% of Gross Profit	5393.33%	1597.28%
Operating Expenses	$469.0K	$425.4K	$140.9K
YoY Change	254.77%	201.86%	-9.78%
Operating Profit	-$468.4K	-$423.6K	-$140.9K
YoY Change	254.32%	200.58%	-5.28%
Interest Expense		$24.00	$1.167K
YoY Change		-97.94%	-371.4%
% of Operating Profit
Other Income/Expense, Net	$2.163K	$8.340K	-$1.167K
YoY Change	-335.11%	-814.65%	168.89%
Pretax Income	-$466.2K	-$415.2K	-$142.1K
YoY Change	250.24%	192.24%	-6.73%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$466.2K	-$415.2K	-$142.1K
YoY Change	250.24%	192.24%	-6.73%
Net Earnings / Revenue	-46619.1%	-13841.2%
Basic Earnings Per Share	-$0.04	-$0.03	-$0.01
Diluted Earnings Per Share	-$0.04	-$0.03	-$13.82K
COMMON SHARES
Basic Shares Outstanding	12.03M shares	12.03M shares	10.28M shares
Diluted Shares Outstanding	12.04M shares	12.03M shares	10.28M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$138.7K	$596.4K	$19.89K
YoY Change	9.35%	2898.54%	-92.66%
Cash & Equivalents	$138.6K	$596.4K	$19.89K
Short-Term Investments
Other Short-Term Assets	$6.760K	$6.760K	$294.2K
YoY Change	-97.7%	-97.7%	83.95%
Inventory	$72.90K	$73.30K
Prepaid Expenses		$6.759K	$294.2K
Receivables
Other Receivables
Total Short-Term Assets	$218.3K	$676.5K	$314.1K
YoY Change	-48.14%	115.37%	-27.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$301.4K	$314.1K	$60.26K
YoY Change	460.51%	421.21%	-57.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.390K	$4.390K
YoY Change
Total Long-Term Assets	$950.7K	$947.3K	$118.0K
YoY Change	789.41%	702.99%	-17.57%
TOTAL ASSETS
Total Short-Term Assets	$218.3K	$676.5K	$314.1K
Total Long-Term Assets	$950.7K	$947.3K	$118.0K
Total Assets	$1.169M	$1.624M	$432.1K
YoY Change	121.45%	275.81%	-24.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$630.9K	$636.4K	$62.58K
YoY Change	961.36%	916.91%	174.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$654.1K	$662.1K	$430.6K
YoY Change	41.14%	53.76%	98.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$46.26K	$56.82K	$33.81K
YoY Change	54.72%	68.06%
Total Long-Term Liabilities	$46.26K	$56.82K	$33.81K
YoY Change	54.72%	68.06%	-32.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$654.1K	$662.1K	$430.6K
Total Long-Term Liabilities	$46.26K	$56.82K	$33.81K
Total Liabilities	$700.4K	$719.0K	$464.4K
YoY Change	41.96%	54.8%	73.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.463M	-$2.997M	-$1.686M
YoY Change	90.34%	77.72%
Common Stock	$12.04K	$12.03K	$10.28K
YoY Change	16.51%	17.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$468.6K	$904.8K	-$32.39K
YoY Change
Total Liabilities & Shareholders Equity	$1.169M	$1.624M	$432.1K
YoY Change	121.45%	275.81%	-24.71%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$466.2K	-$415.2K	-$142.1K
YoY Change	250.24%	192.24%	-6.73%
Depreciation, Depletion And Amortization	$32.36K	$28.75K	$8.117K
YoY Change	399.07%	254.21%	-22.84%
Cash From Operating Activities	-$393.0K	-$282.0K	-$101.7K
YoY Change	322.09%	177.37%	-12.3%
INVESTING ACTIVITIES
Capital Expenditures	$42.49K	$362.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$52.31K
YoY Change
Cash From Investing Activities	-$94.80K	-$362.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.00K	0.000	0.000
YoY Change	-85.0%		-100.0%
NET CHANGE
Cash From Operating Activities	-393.0K	-282.0K	-101.7K
Cash From Investing Activities	-94.80K	-362.0K
Cash From Financing Activities	30.00K	0.000	0.000
Net Change In Cash	-457.8K	-644.0K	-101.7K
YoY Change	-528.22%	533.41%	-1780.5%
FREE CASH FLOW
Cash From Operating Activities	-$393.0K	-$282.0K	-$101.7K
Capital Expenditures	$42.49K	$362.0K
Free Cash Flow	-$435.5K	-$644.0K
YoY Change	367.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001496690
CY2023Q3	BCRD	Stock Subscription Received StockSubscriptionReceived		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2022Q3	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	BCRD	Increase Decrease In Compensation Payable IncreaseDecreaseInCompensationPayable		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	BCRD	Sale Of Vehicle SaleOfVehicle		usd
	BCRD	Repayment Of Loan Payable RepaymentOfLoanPayable		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization		usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56060
	dei	Entity Registrant Name EntityRegistrantName	BlueOne Card, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0478989
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4695 MacArthur Court
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Newport Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92660
	dei	City Area Code CityAreaCode	(800)
	dei	Local Phone Number LocalPhoneNumber	210-9755
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12033704	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	596407	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	668118	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	73300	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	74500	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6759	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7048	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	676466	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	749666	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	314059	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47287	usd
CY2023Q3	BCRD	Internal Use Software Development InternalUseSoftwareDevelopment	528893	usd
CY2023Q1	BCRD	Internal Use Software Development InternalUseSoftwareDevelopment	145892	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	99935	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	48401	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4391	usd
CY2023Q3	us-gaap	Assets Assets	1623744	usd
CY2023Q1	us-gaap	Assets Assets	991246	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	126198	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	79543	usd
CY2023Q3	BCRD	Compensation Payable CompensationPayable	471500	usd
CY2023Q1	BCRD	Compensation Payable CompensationPayable	380750	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38681	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17384	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	662144	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	503442	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56823	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24862	usd
CY2023Q3	us-gaap	Liabilities Liabilities	718967	usd
CY2023Q1	us-gaap	Liabilities Liabilities	528304	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	292	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	292	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12033704	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12033704	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10336004	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10336004	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	12034	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10336	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3889228	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2093226	usd
CY2023Q1	BCRD	Stock Subscription Received StockSubscriptionReceived	617700	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2996777	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2258612	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	904777	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	462942	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1623744	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	991246	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1200	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12033704	shares
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1200	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1800	usd
	us-gaap	Gross Profit GrossProfit	1800	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	11882	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	4524	usd
	us-gaap	Legal Fees LegalFees	14591	usd
	us-gaap	Legal Fees LegalFees	21775	usd
CY2023Q3	BCRD	Rent Expense RentExpense	37790	usd
CY2022Q3	BCRD	Rent Expense RentExpense	26400	usd
	BCRD	Rent Expense RentExpense	75579	usd
	BCRD	Rent Expense RentExpense	46737	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	375704	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	109995	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	658711	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	475327	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	425376	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	140919	usd
	us-gaap	Operating Expenses OperatingExpenses	748881	usd
	us-gaap	Operating Expenses OperatingExpenses	543839	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-423576	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-140919	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-747081	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-543839	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	8364	usd
	us-gaap	Interest Income Other InterestIncomeOther	8957	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	24	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1167	usd
	us-gaap	Interest Expense InterestExpense	41	usd
	us-gaap	Interest Expense InterestExpense	2591	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8340	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1167	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8916	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2591	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-415236	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-142086	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-738165	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-546430	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-415236	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-142086	usd
	us-gaap	Net Income Loss NetIncomeLoss	-738165	usd
	us-gaap	Net Income Loss NetIncomeLoss	-546430	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12033704	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10278861	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10278861	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11714684	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11714684	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10253916	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10253916	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1320013	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-415236	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	904777	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	462942	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1180000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-738165	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	904777	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	109697	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-142086	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-32389	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	91541	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	91541	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	172500	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	250000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-546430	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-32389	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-32389	usd
	us-gaap	Net Income Loss NetIncomeLoss	-738165	usd
	us-gaap	Net Income Loss NetIncomeLoss	-546430	usd
	us-gaap	Depreciation Depreciation	46777	usd
	us-gaap	Depreciation Depreciation	19501	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-2034	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2667	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7523	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	250000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1200	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-289	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	23700	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	46655	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7265	usd
	BCRD	Increase Decrease In Compensation Payable IncreaseDecreaseInCompensationPayable	90750	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	108046	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-555161	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-190807	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	383001	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	313549	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-696550	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1180000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	172500	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3126	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1180000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	169374	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-71711	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21433	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	668118	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41318	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	596407	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19885	usd
	us-gaap	Interest Paid Net InterestPaidNet	41	usd
	us-gaap	Interest Paid Net InterestPaidNet	2591	usd
	BCRD	Sale Of Vehicle SaleOfVehicle	50246	usd
	BCRD	Repayment Of Loan Payable RepaymentOfLoanPayable	50246	usd
	BCRD	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	132957	usd
	BCRD	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	50190	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_zRdt8AiGL4w6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_824_ztysrfSxIfsc">NATURE OF OPERATIONS, GOING CONCERN AND BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">General</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BlueOne Card, Inc. (the “Company”) was incorporated on July 6, 2007 under the laws of the state of Nevada. The Company provides innovative payout solutions and prepaid debit card and gift card solutions to consumers and corporations transforming card-to-card cross border real time global money transfers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Risk and Uncertainty Concerning COVID-19 Pandemic</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The global COVID-19 pandemic continues to present uncertainty and unforeseeable risks to the Company’s operations and business plan. The Company has closely monitored recent developments, including the lifting of COVID-19 safety measures, the spread of new strains or variants of the coronavirus (such as the Delta and Omicron variants), and supply chain and labor shortages. Thus, the full impact of the COVID-19 pandemic on the business and operations remains uncertain and will vary depending on the pandemic’s future impact on the third parties with whom the Company does business, as well as any legal or regulatory consequences resulting therefrom. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members and may take further actions that alter our operations, including any required by federal, state or local authorities, or that it determines are in the best interests of its employees and other third parties with whom the Company does business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These condensed financial statements have been prepared on a going concern basis which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has not yet generated any significant revenues and has suffered operating losses since July 6, 2007 (Inception Date) to date. The Company recorded a net loss of $<span id="xdx_906_eus-gaap--NetIncomeLoss_iN_di_c20230401__20230930_zsrfE8RZ48r8" title="Net income loss">738,165</span>, and used net cash flows in operating activities of $<span id="xdx_909_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230401__20230930_zggmQR7P5fWf" title="Net cash provided by (used in) operating activities">555,161</span> during the six months ended September 30, 2023, and has an accumulated deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230930_zKOn1jdIgoU9" title="Accumulated deficit">2,996,777</span> as of September 30, 2023. These factors, among others, raise a substantial doubt regarding the Company’s ability to continue as a going concern operation for a period of 12 months from the issuance date of these condensed financial statements. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitability. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying condensed financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The interim unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and include the accounts of the Company. The preparation of interim condensed financial statements requires management to make assumptions and estimates that impact the amounts reported. The interim condensed financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. These interim condensed financial statements, reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the Company’s results of operations, financial position and cash flows for the interim periods ended September 30, 2023 and 2022; however, certain information and footnote disclosures normally included in our audited annual financial statements, as included in the Company’s interim condensed financial statements, have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. These unaudited condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2023, filed with the SEC on July 14, 2023. It is important to note that the Company’s results of operations and cash flows for interim periods are not necessarily indicative of the results of operations and cash flows to be expected for a full fiscal year or any other interim period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BLUEONE CARD, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-738165	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-555161	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2996777	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zLmigtPgH475" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_zM8p0XcVJhAa">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of its assets, liabilities, equity and operations. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about its estimates that are not readily apparent from other sources. Significant estimates in the accompanying financial statements include the valuation of inventory, valuation of internal-use software development costs, valuation of lease liabilities and right-of-use assets, valuation of stock-based compensation and valuation of deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zuc6H3FCEGUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_z9QkHXvWKXRl">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash Concentration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash is maintained at one financial institution and at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances. As of September 30, 2023, the Company had balances in a financial institution which exceeded federally insured limits by approximately $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zHLKOzpIOYZ" title="Cash, FDIC insured amount">346,400</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operation and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Vendor and Concentration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company relies solely on one vendor for key components and processing services related to the manufacturing, distribution and servicing of its prepaid debit cards and gift cards. The same vendor is also the sole developer and provider of the software for Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	346400	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	415236	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	142086	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12033704	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12033704	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10278861	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10278861	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-738165	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-546430	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11714684	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11714684	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10253916	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10253916	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	292000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	292000000	shares
CY2023Q3	us-gaap	Other Inventory OtherInventory	99685	usd
CY2023Q1	us-gaap	Other Inventory OtherInventory	100885	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	73300	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	74500	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	439568	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	126019	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	125509	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78732	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	314059	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47287	usd
CY2023Q3	us-gaap	Depreciation Depreciation	28751	usd
	us-gaap	Depreciation Depreciation	46777	usd
CY2022Q3	us-gaap	Depreciation Depreciation	8117	usd
	us-gaap	Depreciation Depreciation	19501	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	145892	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	383001	usd
CY2023Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	528893	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	145892	usd
CY2023Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	528893	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	145892	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	99935	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38681	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56823	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	95504	usd
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-07-11
CY2023Q3	us-gaap	Payments For Rent PaymentsForRent	35768	usd
	us-gaap	Payments For Rent PaymentsForRent	73558	usd
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	26400	usd
	us-gaap	Payments For Rent PaymentsForRent	46737	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12033704	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12033704	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10336004	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10336004	shares
CY2023Q3	us-gaap	Debt Instrument Convertible Liquidation Preference Per Share DebtInstrumentConvertibleLiquidationPreferencePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	292000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	292000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	292000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	292000	shares

Files In Submission

Name	View Source	Status
0001493152-23-041252-index-headers.html	Edgar Link	pending
0001493152-23-041252-index.html	Edgar Link	pending
0001493152-23-041252.txt	Edgar Link	pending
0001493152-23-041252-xbrl.zip	Edgar Link	pending
bcrd-20230930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
bcrd-20230930_cal.xml	Edgar Link	unprocessable
bcrd-20230930_def.xml	Edgar Link	unprocessable
bcrd-20230930_lab.xml	Edgar Link	unprocessable
bcrd-20230930_pre.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BCRD
BlueOne Card, Inc. Stock $bcrd

2023 Q4 Form 10-Q Financial Statement

#000149315223041252 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BCRD BlueOne Card, Inc. Stock $bcrd

2023 Q4 Form 10-Q Financial Statement

#000149315223041252 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BCRD
BlueOne Card, Inc. Stock $bcrd